Company
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Standardized SEC financial data for BRIGHT MINDS BIOSCIENCES INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001827401 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-50.6%
Income statement
| C$ | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| R&D expense | C$355K | C$6.3M | C$12.2M | C$5.0M | C$1.2M |
| SG&A expense | C$637 | C$197K | C$478K | C$279K | C$264K |
| Net income | -C$480K | -C$2.8M | -C$15.0M | -C$7.4M |
Standardized from BRIGHT MINDS BIOSCIENCES INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| C$ | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total assets | — | C$880K | C$20.0M | C$12.1M | C$6.9M | C$6.1M |
| Total liabilities |
Get DRUG data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DRUG/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DRUG/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"